n.a. (TKMR)

4.02
0.08 1.95
NASDAQ
Prev Close 4.10
Open 4.22
Day Low/High 3.98 / 4.33
52 Wk Low/High 4.01 / 26.73
Volume 346.21K
Exchange NASDAQ
P/E Ratio N/A
Div & Yield N.A. (N.A)
Interesting TKMR Put And Call Options For December 12th

Interesting TKMR Put And Call Options For December 12th

Investors in Tekmira Pharmaceuticals Corp saw new options become available today, for the December 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new December 12th contracts and identified one put and one call contract of particular interest.

December 5th Options Now Available For Tekmira Pharmaceuticals (TKMR)

December 5th Options Now Available For Tekmira Pharmaceuticals (TKMR)

Investors in Tekmira Pharmaceuticals Corp saw new options begin trading today, for the December 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new December 5th contracts and identified one put and one call contract of particular interest.

Tekmira Pharmaceuticals (TKMR) Highlighted As Today's Perilous Reversal Stock

Tekmira Pharmaceuticals (TKMR) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "perilous reversal" (up big yesterday but down big today) candidate

Heavy Volume And Pre-Market Movement For Tekmira Pharmaceuticals (TKMR)

Heavy Volume And Pre-Market Movement For Tekmira Pharmaceuticals (TKMR)

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a pre-market mover with heavy volume candidate

Tekmira Provides Periodic Update On TKM-Ebola Program

Tekmira Provides Periodic Update On TKM-Ebola Program

Commences Manufacture of New RNAi Therapeutic for Ebola - Guinea Variant

Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock

Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "dead cat bounce" (down big yesterday but up big today) candidate

Sarepta Soars After Announcing Publication of Ebola Drug Candidate Data

Sarepta Soars After Announcing Publication of Ebola Drug Candidate Data

Shares of Sarepta Therapeutics are soaring this morning following the publication of Phase I clinical study results for its Ebola and Marburg virus drug candidates.

Tekmira Presents Results Of Preclinical Studies With Hepatitis B Therapeutic

Tekmira Presents Results Of Preclinical Studies With Hepatitis B Therapeutic

Demonstrates Robust Knockdown of HBV Surface Antigen

Ebola Linked Names Rise Again Amid Broader Market Sell-Off

Ebola Linked Names Rise Again Amid Broader Market Sell-Off

Shares of companies leveraged to Ebola are rising again after a second health care worker in the U.S. tested positive for the illness.

Tekmira's Partner Reports Positive Clinical Data For LNP-Enabled Patisiran

Tekmira's Partner Reports Positive Clinical Data For LNP-Enabled Patisiran

Tekmira's LNP Technology Enables Treatment With Favorable Tolerability Profile for a Period of Up to One Year

'Fast Money' Recap: How to Trade in a Volatile Marketplace

'Fast Money' Recap: How to Trade in a Volatile Marketplace

The trading panel discussed defensive trades, the state of the market and whether Carl Icahn is right about Apple.

Lakeland Industries Continues To Surge Amid Ebola Fears

Lakeland Industries Continues To Surge Amid Ebola Fears

Shares of Lakeland Industries, which supplies protective clothing to the Centers for Disease Control and other governmental agencies, are soaring amid continued fears over the Ebola outbreak...

Stocks Pop on FOMC Minutes; Icahn Tweets to Apple; J.C. Penney Falls

Stocks Pop on FOMC Minutes; Icahn Tweets to Apple; J.C. Penney Falls

Stocks popped at the release of the FOMC minutes.

'Fast Money Halftime Report': U.S. Stocks Rebound, but Traders Look for a Pullback

'Fast Money Halftime Report': U.S. Stocks Rebound, but Traders Look for a Pullback

The trading panel discusses energy and retail stocks, as well as whether the market has further downside ahead. GM CEO Mary Barra, a guest, talked about GM's future.

Stock Market Today: Stocks Spike as Fed Minutes Allay Fears of Rate Hike

Stock Market Today: Stocks Spike as Fed Minutes Allay Fears of Rate Hike

U.S. stocks popped on Wednesday after the release of the Federal Reserve minutes which allayed fears an interest rate hike could come sooner than expected.

Ebola Outbreak Puts the Spotlight on 10 Biotech Companies

Ebola Outbreak Puts the Spotlight on 10 Biotech Companies

The Ebola outbreak has put the spotlight on Chimerix as well as other biotech companies with potential vaccines and even those stocks with marginal relation to the virus.

Tekmira Pharmaceuticals (TKMR) Is Strong On High Volume Today

Tekmira Pharmaceuticals (TKMR) Is Strong On High Volume Today

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a strong on high relative volume candidate

The Disgusting Reaction to Ebola Patient's Death by Tekmira, Chimerix Traders

The Disgusting Reaction to Ebola Patient's Death by Tekmira, Chimerix Traders

Tekmira shares surge after Thomas Duncan's death announced.

'Fast Money' Recap: What Should You Buy in a Declining Market?

'Fast Money' Recap: What Should You Buy in a Declining Market?

The trading panel discusses Yum! Brands, the mining industry and Ebola treatments.

Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock

Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "dead cat bounce" (down big yesterday but up big today) candidate

'Fast Money' Recap: Is HP Split the Right Move for Investors?

'Fast Money' Recap: Is HP Split the Right Move for Investors?

The trading panel discussed what other companies would benefit by splitting themselves and the extent of cyber crime.

Why Tekmira Pharmaceuticals (TKMR) Stock Is Tanking Today

Why Tekmira Pharmaceuticals (TKMR) Stock Is Tanking Today

Tekmira Pharmaceuticals (TKMR) shares are down double digits after having its rating downgraded to 'market perform' by analysts at Leerink Swann.

Tekmira Pharmaceuticals (TKMR) Is Weak On High Volume Today

Tekmira Pharmaceuticals (TKMR) Is Weak On High Volume Today

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a weak on high relative volume candidate

'Fast Money' Recap: Roller-Coaster Week Ends With a Rally

'Fast Money' Recap: Roller-Coaster Week Ends With a Rally

The trading panel discussed emerging markets, volatility and how to trade on the dollar.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

The U.S. is stronger than we thought, Cramer says, but will it last?

Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining Today

Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining Today

Tekmira Pharmaceuticals (TKMR) shares had their price target raised to $31 by analysts at Maxim Group on Friday.

The Whoosh I Wanted

The market broke a line.